Jay Olson

Oppenheimer | Healthcare

Jay Olson is an analyst from Oppenheimer specializing in the Healthcare sector. Ranked #1059 out of 4745 analysts, they have issued 30 stock ratings with a success rate of 75.89% and an average return of 34.76%.

Jay Olson has a well-established track record, with 30 ratings issued in the Healthcare sector. They have consistently delivered a success rate of 75.89% and an average return of 34.76%, underscoring their expertise and ability to identify winning opportunities for investors.

#1059

Out of 4745

30

Total Ratings

+75.89%

Success Rate

+34.76%

Average Return

Recent Ratings Analysis

FTH

Jul 28, 2026

Target

$60.00

Current

$29.24

Performance

—

Jay Olson rated FTH as Outperform on Jul 28, 2026, setting a price target of 60. Shares have remained stable near 29.24, leaving the 60 target still in play.

QTTB

Jul 13, 2026

Target

$40.00

Current

$15.21

Performance

-28.86%

On Jul 13, 2026, QTTB was given a Outperform rating by Jay Olson, with a target price of 40. Despite the Buy call, shares fell from 15.21 to 15.21, challenging the optimistic stance.

KYNB

Jul 07, 2026

Target

$35.00

Current

$7.05

Performance

-6.50%

KYNB received a Outperform rating from Jay Olson on Jul 07, 2026, aiming for 35. The rating hasn’t played out as hoped, with the stock trading 6.50% below expectations.

EPRX

Jun 26, 2026

Target

$17.00

Current

$6.17

Performance

-6.52%

On Jun 26, 2026, Jay Olson published a Outperform outlook on EPRX, with a target of 17. Market action contradicted the Buy thesis, as shares slipped to 6.17.

DFTX

Jun 22, 2026

Target

$60.00

Current

$42.65

Performance

16.31%

Jay Olson on Jun 22, 2026 assigned DFTX a Outperform rating, with a price target of 60. The Buy call aligned well with market performance, producing a gain of 16.31%.

PRAX

Jun 02, 2026

Target

$650.00

Current

$315.80

Performance

—

On Jun 02, 2026, Jay Olson reaffirmed PRAX with a Outperform rating, targeting 650. Market indecision has kept the 650 target in a holding pattern.

RVMD

Jun 01, 2026

Target

$195.00

Current

$188.07

Performance

14.90%

RVMD was rated Outperform by Jay Olson on Jun 01, 2026, with a price objective of 195. A bullish response from the market helped close the gap of 6.93 to the target.

ANL

May 28, 2026

Target

$32.00

Current

$12.06

Performance

6.73%

On May 28, 2026, Jay Olson initiated coverage on ANL with a Outperform rating and target of 32. The stock’s climb of 6.73% since the call highlights the foresight in the rating.

INCY

Apr 29, 2026

Target

$90.00

Current

$118.87

Performance

19.95%

Jay Olson issued a Perform recommendation for INCY on Apr 29, 2026, price target set at 90. A neutral call gave way to stronger-than-expected performance, closing in on 90.

PASG

Apr 21, 2026

Target

$15.00

Current

$4.62

Performance

-25.24%

On Apr 21, 2026, PASG was evaluated by Jay Olson, who gave a Outperform rating and target of 15. Investors saw limited payoff as shares fell short of the 15 target.

BIIB

Apr 01, 2026

Target

$275.00

Current

$200.14

Performance

8.90%

Jay Olson rated BIIB as Outperform on Apr 01, 2026, setting a price target of 275. The call has proven timely, with shares rising 8.90% toward the price target of 275.

BCYC

Mar 18, 2026

Target

$36.00

Current

$3.95

Performance

-15.96%

On Mar 18, 2026, BCYC was given a Outperform rating by Jay Olson, with a target price of 36. Despite the Buy call, shares fell from 3.95 to 3.95, challenging the optimistic stance.

VRTX

Mar 10, 2026

Target

$600.00

Current

$479.00

Performance

-4.04%

VRTX received a Outperform rating from Jay Olson on Mar 10, 2026, aiming for 600. Price action was muted, as shares hovered around 479 despite the bullish outlook.

BIOA

Feb 25, 2026

Target

$60.00

Current

$20.88

Performance

-5.69%

On Feb 25, 2026, Jay Olson published a Outperform outlook on BIOA, with a target of 60. Market action contradicted the Buy thesis, as shares slipped to 20.88.

ACAD

Feb 06, 2026

Target

$23.00

Current

$25.39

Performance

7.77%

Jay Olson on Feb 06, 2026 assigned ACAD a Perform rating, with a price target of 23. Shares outperformed expectations, climbing 7.77% despite the neutral view.

CHRS

Jan 22, 2026

Target

$10.00

Current

$1.46

Performance

-8.18%

On Jan 22, 2026, Jay Olson reaffirmed CHRS with a Outperform rating, targeting 10. Shares slid 8.18% despite the recommendation, highlighting downside risks.

TERN

Dec 09, 2025

Target

$58.00

Current

$52.95

Performance

24.38%

TERN was rated Outperform by Jay Olson on Dec 09, 2025, with a price objective of 58. A bullish response from the market helped close the gap of 5.05 to the target.

MDGL

Nov 20, 2025

Target

$650.00

Current

$551.25

Performance

1.68%

On Nov 20, 2025, Jay Olson initiated coverage on MDGL with a Outperform rating and target of 650. Neutral price movement of 1.68% leaves room for interpretation.

IBIO

Oct 21, 2025

Target

$5.00

Current

$1.45

Performance

30.63%

Jay Olson issued a Outperform recommendation for IBIO on Oct 21, 2025, price target set at 5. Investors following the Buy call captured upside momentum, with shares now at 1.45.

IONS

Oct 08, 2025

Target

$90.00

Current

$55.96

Performance

-20.01%

On Oct 08, 2025, IONS was evaluated by Jay Olson, who gave a Outperform rating and target of 90. Investors saw limited payoff as shares fell short of the 90 target.

IMRX

Sep 25, 2025

Target

$30.00

Current

$4.36

Performance

-45.50%

Jay Olson rated IMRX as Outperform on Sep 25, 2025, setting a price target of 30. The stock has underperformed, dropping 45.50% despite the bullish target of 30.

MNMD

Aug 04, 2025

Target

$25.00

Current

$20.69

Performance

121.05%

On Aug 04, 2025, MNMD was given a Outperform rating by Jay Olson, with a target price of 25. The stock rallied 121.05% after the rating, narrowing the gap to the target of 25 and validating the bullish stance.

ATAI

Jul 29, 2025

Target

$14.00

Current

$7.17

Performance

116.62%

ATAI received a Outperform rating from Jay Olson on Jul 29, 2025, aiming for 14. Momentum has favored the Buy call, with shares climbing from 7.17 to 7.17, rewarding those who trusted the recommendation.

PRTA

May 27, 2025

Target

—

Current

$8.70

Performance

89.96%

On May 27, 2025, Jay Olson published a Perform outlook on PRTA, with a target of null. The Hold call missed some of the bullish momentum as shares advanced toward null.

JSPR

May 15, 2025

Target

$65.00

Current

$0.69

Performance

-85.74%

Jay Olson on May 15, 2025 assigned JSPR a Outperform rating, with a price target of 65. The call has struggled to gain traction, with shares losing 85.74%.

NKTR

Mar 14, 2025

Target

$6.00

Current

$71.35

Performance

7856.07%

On Mar 14, 2025, Jay Olson reaffirmed NKTR with a Outperform rating, targeting 6. The recommendation was supported by strong follow-through as the stock rose from 71.35 to 71.35.

DNLI

Mar 03, 2025

Target

$42.00

Current

$23.57

Performance

55.07%

DNLI was rated Outperform by Jay Olson on Mar 03, 2025, with a price objective of 42. A bullish response from the market helped close the gap of 18.43 to the target.

EXEL

Jan 24, 2025

Target

$33.00

Current

$55.81

Performance

72.36%

On Jan 24, 2025, Jay Olson initiated coverage on EXEL with a Perform rating and target of 33. The Hold stance underestimated the stock’s strength as it gained 72.36%.

NTLA

Jan 13, 2025

Target

$40.00

Current

$10.67

Performance

6.17%

Jay Olson issued a Outperform recommendation for NTLA on Jan 13, 2025, price target set at 40. Investors following the Buy call captured upside momentum, with shares now at 10.67.

SGMT

Dec 06, 2024

Target

$30.00

Current

$7.45

Performance

46.08%

On Dec 06, 2024, SGMT was evaluated by Jay Olson, who gave a Outperform rating and target of 30. This case illustrates how a timely bullish rating can translate into tangible gains of 46.08%.

INO

Nov 18, 2024

Target

$15.00

Current

$0.97

Performance

-76.35%

Jay Olson rated INO as Outperform on Nov 18, 2024, setting a price target of 15. The stock has underperformed, dropping 76.35% despite the bullish target of 15.

GLTO

Oct 17, 2024

Target

$10.00

Current

$21.58

Performance

220.65%

On Oct 17, 2024, GLTO was given a Outperform rating by Jay Olson, with a target price of 10. The stock rallied 220.65% after the rating, narrowing the gap to the target of 10 and validating the bullish stance.

VKTX

Sep 25, 2024

Target

$138.00

Current

$34.87

Performance

-44.76%

VKTX received a Outperform rating from Jay Olson on Sep 25, 2024, aiming for 138. The rating hasn’t played out as hoped, with the stock trading 44.76% below expectations.

MRNS

Sep 23, 2024

Target

$6.00

Current

$0.55

Performance

-66.26%

On Sep 23, 2024, Jay Olson published a Outperform outlook on MRNS, with a target of 6. Market action contradicted the Buy thesis, as shares slipped to 0.55.

GANX

Aug 14, 2024

Target

$8.00

Current

$1.86

Performance

66.07%

Jay Olson on Aug 14, 2024 assigned GANX a Outperform rating, with a price target of 8. The Buy call aligned well with market performance, producing a gain of 66.07%.

NBIX

Aug 02, 2024

Target

$219.00

Current

$176.41

Performance

15.20%

On Aug 02, 2024, Jay Olson reaffirmed NBIX with a Outperform rating, targeting 219. The recommendation was supported by strong follow-through as the stock rose from 176.41 to 176.41.

EDIT

Jun 18, 2024

Target

$12.00

Current

$2.68

Performance

-46.83%

EDIT was rated Perform by Jay Olson on Jun 18, 2024, with a price objective of 12. Investors who stayed cautious avoided some of the 46.83% decline.

CRSP

May 10, 2024

Target

$95.00

Current

$46.73

Performance

-8.68%

On May 10, 2024, Jay Olson initiated coverage on CRSP with a Outperform rating and target of 95. The Buy call has yet to be validated as shares remain 48.27 away from the target.

Frequency Asked Questions

Who is Jay Olson?

Jay Olson is an analyst from Oppenheimer specializing in the Healthcare sector.

What is Jay Olson's success rate?

Jay Olson currently has a success rate of +75.89%.

How many ratings has Jay Olson issued?

Jay Olson has issued 30 stock ratings so far.

What is the average return of Jay Olson's calls?

Their stock ratings have generated an average return of +34.76%.

What is Jay Olson's ranking?

Jay Olson is ranked #1059 out of 4745 analysts.

What types of ratings does Jay Olson give?

Their ratings include Buy, Hold, and Sell recommendations, depending on the stock’s outlook.

How can I follow Jay Olson?

You can follow Jay Olson by clicking the "Follow Analyst" button on this page to receive updates on their stock calls.

What is the most recent rating by Jay Olson?

Their latest rating was a Buy on FTH issued on 2026-07-28.

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

Stocks Telegraph does not provide any advice or recommendations for buying or selling stocks, securities, or other financial products. Information contained on this website is for informational purposes only and should not be construed as professional financial, investment or other advice. Stocks Telegraph is not liable for any loss or damage that may occur as a result of reliance on this data.

© 2026 Stocks Telegraph All rights reserved.
Most stock quote data provided by Financial Modeling Prep